The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Measurements matters: the case for 3D MSCT software for aortic annulus quantification

EuroIntervention 2014;10:294-295. DOI: 10.4244/EIJV10I3A50

Department of Interventional Cardiology, McGill University Health Centre, Montreal, Quebec, Canada
Up until 2010, paravalvular aortic regurgitation (pAR) of any severity was diagnosed in 70-90% of patients after transcatheter aortic valve implantation (TAVI) using either a self- or balloon-expanding prosthesis; moderate to severe pAR was observed in 10-30%1. During the last two years, moderate to severe pAR has been documented in 0-12% of patients undergoing TAVI (Figure 1), including those patients implanted with the Medtronic CoreValve (Medtronic, Minneapolis, MN, USA), a valve which has not undergone significant iterations until recently. What can explain the significant reductions in pAR over time?

Figure 1. Rates of significant paravalvular aortic regurgitation (>2+) across various transcatheter ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Hybrid intravascular imaging: the key for a holistic evaluation of plaque pathology